{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:27:26Z","timestamp":1768595246824,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sweet\u2019s syndrome (SS), also known as acute febrile neutrophilic skin disease, is a rare inflammatory skin disease. Clinically, patients often have fever and leukocytosis, characterized by painful erythema, papules or pustules. According to different etiologies, SS can be classified into three types: idiopathic, tumor-related and drug-induced. Among them, tumor-associated SS is closely related to some hematological malignancies. Drug-induced SS, on the other hand, can be induced by the use of granulocyte colony-stimulating factor (G-CSF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case introduction<\/jats:title>\n                    <jats:p>This article reports a 42-year-old male patient who was admitted to the hospital due to \u201csignificant splenomegaly and splenic stasis.\u201d After admission, the patient was diagnosed with primary myelofibrosis through examination. During the hospitalization process, the patient received G-CSF treatment and open total splenectomy. On the 8th day after subcutaneous injection of 100 \u03bcg of G-CSF, erythema, swelling and superficial ulcers occurred at the surgical incision and drainage site, accompanied by Koebner\u2019s phenomenon. The results of skin biopsy indicated Sweet\u2019s syndrome. The rash improved significantly and rapidly several days after intravenous application of methylprednisolone. However, several months after discharge, the patient was diagnosed with acute myeloid leukemia through bone marrow puncture in another hospital and unfortunately passed away due to the progression of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients with complex underlying diseases such as myelofibrosis and receiving G-CSF treatment, Sweet\u2019s syndrome may not only be an adverse reaction caused by drugs, but more likely to be an early manifestation of leukemia. At this time, SS is a complex comprehensive disease caused by multiple factors. It is not advisable to simply diagnose its phenotype. Instead, a comprehensive assessment should be conducted to reduce misdiagnosis and missed diagnosis. Therefore, in clinical practice, we should strengthen multidisciplinary collaboration even more and enhance the understanding of Sweet\u2019s syndrome itself and its role as a potential early warning signal of leukemia. This enables the early identification of diseases and the adoption of effective treatment measures. Although the Koebner phenomenon is relatively rare in SS, its occurrence should be highly valued.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1632767","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:18:35Z","timestamp":1762751915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sweet\u2019s syndrome with Koebner phenomenon triggered by G-CSF as a preleukemic manifestation in a patient with primary myelofibrosis: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhiyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome\u2013a comprehensive review of an acute febrile neutrophilic dermatosis.","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"Acute febrile neutrophilic dermatosis.","volume":"90","author":"Sweet","year":"1964","journal-title":"Arch Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2019.00414","article-title":"Insights into the pathogenesis of sweet\u2019s syndrome.","volume":"10","author":"Heath","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40257-022-00673-4","article-title":"New practical aspects of sweet syndrome.","volume":"23","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/s0190-9622(96)90080-8","article-title":"Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet\u2019s syndrome.","volume":"34","author":"Walker","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12288-014-0420-2","article-title":"Granulocyte colony stimulating factor induced Sweet\u2019ssyndrome following autologous transplantation in a child with relapsed acutemyeloblastic leukemia.","author":"Kaya","year":"2014","journal-title":"Indian J Hematol Blood Transfus."},{"key":"B7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00403-024-03414-1","article-title":"Clinical features, treatment, and outcome of granulocyte colony stimulating factor-induced sweet syndrome.","volume":"316","author":"Wu","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1111\/bcp.15873","article-title":"Signal for sweet syndrome associated with granulocyte colony-stimulating factors: a case\/non-case study in the French Pharmacovigilance Database.","volume":"89","author":"Martin","year":"2023","journal-title":"Br J Clin Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/cup.12042","article-title":"Sweet\u2019s syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case.","volume":"40","author":"Llamas-Velasco","year":"2013","journal-title":"J Cutan Pathol."},{"key":"B10","first-page":"292","article-title":"Sweet\u2019s syndrome and malignancy.","volume":"40","author":"Cohen","year":"2022","journal-title":"Clin Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.det.2023.08.004","article-title":"From histiocytoid Sweet syndrome to myelodysplasia cutis: history and perspectives.","volume":"42","author":"Vignon-Pennamen","year":"2024","journal-title":"Dermatol Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"103289","DOI":"10.1016\/j.critrevonc.2012.09.005","article-title":"Sweet\u2019s syndrome: a revisit for hematologists and oncologists.","volume":"86","author":"Paydas","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jaad.2020.09.089","article-title":"Acute myeloid leukemia and myelodysplastic syndrome-associated Sweet syndrome: a comparative multicenter retrospective study of 39 patients.","volume":"84","author":"Merlant","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review.","volume":"21","author":"Maglie","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmed.2020.00020","article-title":"Insights into the characteristics of Sweet syndrome in patients with and without hematologic malignancy.","volume":"7","author":"Zheng","year":"2020","journal-title":"Front Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000535399","article-title":"Acute febrile Neutrophilic dermatosis (Sweet Syndrome) in acute myeloid leukemia patients: a 28-year institutional experience.","volume":"147","author":"Cowen","year":"2024","journal-title":"Acta Haematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.annder.2022.01.008","article-title":"First case of Sweet\u2019s syndrome after tattooing.","volume":"149","author":"Kluger","year":"2022","journal-title":"Ann Dermatol Venereol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ad.2018.02.006","article-title":"Koebner phenomenon in Sweet\u2019s syndrome after cat scratch.","volume":"109","author":"Hiraiwa","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","article-title":"The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications.","volume":"22","author":"Singh","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/154411130201300405","article-title":"The pathogenesis of oral lichen planus.","volume":"13","author":"Sugerman","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease.","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood.2021011455","article-title":"VEXAS syndrome.","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1632767\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:18:36Z","timestamp":1762751916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1632767\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":22,"alternative-id":["10.3389\/fmed.2025.1632767"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1632767","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1632767"}}